Capitalizing on the messenger: Intra-tumoral delivery of RNA with a systemic effect.

Capitalizing on the messenger: Intra-tumoral delivery of RNA with a systemic effect.
复制标题

DOI:
10.1016/j.ccell.2021.10.004
复制
发表时间:
2021-11-08
期刊:
影响因子:
50.3
通讯作者:
Ott, Patrick A.
Ott, Patrick A.
中科院分区:
医学1区
文献类型:
--
作者:
Ott, Patrick A.

文献摘要

参考文献

相似文献

如最近在Science Translational Medicine中报道的,肿瘤内施用在盐水中配制的编码4种细胞因子的mRNA介导注射的和远处的鼠肿瘤的消退。在抗PD-1耐药环境中也观察到并通过检查点阻断增强的抗肿瘤作用由肿瘤特异性T细胞和自然杀伤细胞介导。
As reported recently in Science Translational Medicine, intra-tumoral administration of mRNAs encoding 4 cytokines formulated in saline mediates regression of injected and distant murine tumors. The anti-tumor effect, also seen in the anti-PD-1 resistant setting and enhanced by checkpoint blockade, is mediated by tumor-specific T cells and Natural Killer cells.
DOI: 10.1200/jco.1995.13.3.688
发表时间: 1995-03-01
影响因子: 45.3
作者:
FYFE, G;FISHER, RI;LOUIE, AC
通讯作者: LOUIE, AC
DOI: 10.1038/s41551-020-0549-2
发表时间: 2020-04-13
影响因子: 28.1
作者:
Mansurov, Aslan;Ishihara, Jun;Hubbell, Jeffrey A.
通讯作者: Hubbell, Jeffrey A.
在转移性黑色素瘤患者中,用CpG-A Toll样受体9激动剂Vidutolimod克服PD-1阻滞性。
DOI: 10.1158/2159-8290.cd-21-0425
发表时间: 2021-12-01
期刊: Cancer discovery
影响因子: 28.2
作者:
Ribas A;Medina T;Kirkwood JM;Zakharia Y;Gonzalez R;Davar D;Chmielowski B;Campbell KM;Bao R;Kelley H;Morris A;Mauro D;Wooldridge JE;Luke JJ;Weiner GJ;Krieg AM;Milhem MM
通讯作者: Milhem MM
DOI: 10.1016/j.cell.2017.08.027
发表时间: 2017-09-07
期刊: Cell
影响因子: 64.5
作者:
Ribas A;Dummer R;Puzanov I;VanderWalde A;Andtbacka RHI;Michielin O;Olszanski AJ;Malvehy J;Cebon J;Fernandez E;Kirkwood JM;Gajewski TF;Chen L;Gorski KS;Anderson AA;Diede SJ;Lassman ME;Gansert J;Hodi FS;Long GV
通讯作者: Long GV
DOI: 10.1126/scitranslmed.aaw2614
发表时间: 2019-06-26
影响因子: 17.1
作者:
Momin N;Mehta NK;Bennett NR;Ma L;Palmeri JR;Chinn MM;Lutz EA;Kang B;Irvine DJ;Spranger S;Wittrup KD
通讯作者: Wittrup KD